Pentwater Capital Management LP - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Pentwater Capital Management LP ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,492,100
-19.8%
430,000
+7.5%
0.01%
-38.5%
Q2 2023$1,860,000
+57.9%
400,000
+56.9%
0.01%
+18.2%
Q1 2023$1,178,100
-64.9%
255,000
-38.6%
0.01%
-81.4%
Q4 2022$3,353,200
+67.8%
415,000
+15.3%
0.06%
+168.2%
Q3 2022$1,998,000
+0.9%
360,000
-5.3%
0.02%
-4.3%
Q2 2022$1,980,000
-3.6%
380,000
+52.0%
0.02%
-8.0%
Q1 2022$2,055,000
-39.9%
250,000
+8.7%
0.02%
-32.4%
Q4 2021$3,422,000
-13.7%
230,000
+9.5%
0.04%
-7.5%
Q3 2021$3,967,000
+1.6%
210,0000.0%0.04%
+25.0%
Q2 2021$3,904,000
-7.0%
210,000
+13.8%
0.03%
-20.0%
Q1 2021$4,199,000
-32.0%
184,501
-35.1%
0.04%
-46.7%
Q4 2020$6,177,000
+63.9%
284,501
-24.1%
0.08%
+53.1%
Q3 2020$3,769,000
+27.1%
375,000
-1.8%
0.05%
-7.5%
Q2 2020$2,965,000
+290.6%
382,026
+413.6%
0.05%
+307.7%
Q1 2020$759,000
-13.7%
74,385
-6.9%
0.01%
-7.1%
Q4 2019$879,000
+8.5%
79,892
-10.3%
0.01%
+7.7%
Q3 2019$810,000
-28.8%
89,081
-10.9%
0.01%
+8.3%
Q2 2019$1,138,000
-21.4%
100,000
-21.3%
0.01%
-33.3%
Q1 2019$1,447,000
+57.6%
127,005
+24.7%
0.02%
+125.0%
Q4 2018$918,000
-12.6%
101,808
+45.4%
0.01%
-11.1%
Q3 2018$1,050,00070,0000.01%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$13,773,0003.47%
AJU IB Investment Co., Ltd. 175,000$1,439,0002.22%
Frazier Life Sciences Management, L.P. 1,776,479$14,603,0001.24%
First Light Asset Management, LLC 1,672,497$13,748,0001.21%
BVF INC/IL 3,447,946$28,342,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,732,400$30,680,0000.94%
Endurant Capital Management LP 296,508$2,437,0000.64%
Parkman Healthcare Partners LLC 199,846$1,643,0000.48%
Eventide Asset Management 2,708,975$22,268,0000.35%
Lombard Odier Asset Management (Switzerland) SA 391,024$3,214,0000.25%
View complete list of SUTRO BIOPHARMA INC shareholders